$heff's $tation of $tocks & $olid DD

[Br757]

OPTR - For anyone still in this.

http://www.nytimes.com/2011/05/28/health...

Label - Superiority from Bloomberg (excerpt)

The FDA approval of DIFICID is the culmination of Optimer's efforts to develop an innovative therapy for the treatment of CDAD," said Pedro Lichtinger, President and Chief Executive Officer of Optimer. "The clinical development program for DIFICID was designed to address one of the greatest challenges in managing CDAD, disease recurrence. We are proud to provide the medical community and patients with an effective treatment proven to produce sustained clinical response in CDAD, and are now moving into the commercialization stage where we will partner with physicians and health systems to ensure that DIFICID reaches patients in urgent need of an important new treatment option. The recognition in our label of the DIFICID superiority in sustained clinical response will allow the Optimer and Cubist field force to educate the medical community about the advantage DIFICID can offer to appropriate CDAD patients."

http://www.dificid.com/upload/dificid.pd...

Conference call 8 AM (Eastern) - on company's website

Tuesday could be very interesting and dramatic for those of us still in OPTR. If Friday was truly a Bear raid which caught most of us by surprise then we should gap up. I think that the fact that management did not halt trading Friday and there was a delay between the announcement of FDA acceptance and the SUPERIORITY in the LABEL being released created unnecessary anxiety that was ideal for a Bear raid.

Hopefully, Tuesday will reward all the investors who have been long in OPTR.